Document Detail

A review of Parry-Romberg syndrome.
MedLine Citation:
PMID:  22405645     Owner:  NLM     Status:  Publisher    
Parry-Romberg syndrome, also known as progressive hemifacial atrophy, is a rare disorder characterized by unilateral facial atrophy affecting the skin, subcutaneous tissue, muscles, and sometimes extending to the osteocartilaginous structures. It has been associated with various systemic manifestations, particularly neurologic, ophthalmologic and maxillofacial. In this article, we review Parry-Romberg syndrome with its associated findings (neurologic, ophthalmologic, cardiac, rheumatologic, endocrinologic, infectious, orthodontic and maxillofacial, and autoimmune), underlying cause, differential diagnoses (en coup de sabre, scleroderma, and Rasmussen encephalitis), and therapeutic options.
Jessica El-Kehdy; Ossama Abbas; Nelly Rubeiz
Related Documents :
21733535 - Phaces syndrome (pascual castroviejo type ii): prenatal and postnatal magnetic resonanc...
20676475 - Becker nevus syndrome.
3617715 - Treatable dementias.
4819905 - The 'subcortical dementia' of progressive supranuclear palsy.
7748915 - Abdominal syndromes and functional ability in the elderly.
23293495 - Scheuthauer-marie-sainton syndrome.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-3-7
Journal Detail:
Title:  Journal of the American Academy of Dermatology     Volume:  -     ISSN:  1097-6787     ISO Abbreviation:  -     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-3-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7907132     Medline TA:  J Am Acad Dermatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
American University of Beirut Medical Center, Beirut, Lebanon.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Oral glycopyrrolate as second-line treatment for primary pediatric hyperhidrosis.
Next Document:  Synthesis and biological evaluation of novel bifendate derivatives bearing 6,7-dihydro-dibenzo[c,e]a...